The Latest Breaking News from Wall Street

The healthcare industry is expected to witness robust growth driven by increased demand for medicines. Therefore, small-cap Wall Street healthcare favorites Amphastar Pharmaceuticals (AMPH), Catalyst Pharmaceuticals (CPRX), and Equillium (EQ) might be ideal additions to your portfolio. Keep reading….

Visa's stock has been underperforming the broader financial sector, falling from its all-time high. Despite this, Wall Street analysts are optimistic and anticipate upsides in the stock.

As we head into 2024, Wall Street analysts are the most bullish on Amazon in the FAANG space, while the consensus expects Netflix shares to decline over the next year. Here's a closer look at what experts are forecasting for FAANG names next year.

In an era where data is the new currency, cybersecurity measures are more important than ever. Two top cybersecurity players stand out for their efforts to combat online threats, but Wall Street prefers one over the other - here's what investors need to know.

Wall Street took a brief respite during midday trading on Tuesday, marked by modest losses in major stock averages

These 2 growth stocks have earned their place in famous investor Cathie Wood’s flagship Ark Innovation ETF, and Wall Street analysts rushed to raise their price targets after earnings. But are these names a good buy right now?

Asian shares have advanced after Wall Street roared higher on hopes that market-rattling hikes to interest rates are coming to an end

Asian shares are surging after the U.S. Federal Reserve indicated it may not need to pump the brakes any harder on Wall Street and the economy

Meta Platforms will release its Q3 earnings this week. Here's a preview of Wall Street's earnings expectations, plus the 7 things that investors should watch for in the report.